MOGGI PIGNONE, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.798
EU - Europa 8.960
AS - Asia 7.066
SA - Sud America 829
AF - Africa 243
OC - Oceania 125
Continente sconosciuto - Info sul continente non disponibili 2
Totale 31.023
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.629
RU - Federazione Russa 3.264
SG - Singapore 2.107
IT - Italia 2.045
CN - Cina 1.676
HK - Hong Kong 1.032
PL - Polonia 827
VN - Vietnam 772
IE - Irlanda 731
BR - Brasile 655
KR - Corea 596
SE - Svezia 580
DE - Germania 352
FR - Francia 319
FI - Finlandia 295
IN - India 200
GB - Regno Unito 176
UA - Ucraina 170
BD - Bangladesh 143
AU - Australia 120
CA - Canada 102
TR - Turchia 102
JO - Giordania 92
JP - Giappone 90
AR - Argentina 68
ID - Indonesia 65
CI - Costa d'Avorio 44
IQ - Iraq 42
NL - Olanda 38
ES - Italia 34
MX - Messico 33
ZA - Sudafrica 33
EC - Ecuador 29
MA - Marocco 27
CH - Svizzera 23
NG - Nigeria 23
EG - Egitto 22
CO - Colombia 21
BJ - Benin 19
PK - Pakistan 18
TN - Tunisia 18
PY - Paraguay 17
VE - Venezuela 17
AT - Austria 16
BE - Belgio 16
KE - Kenya 16
PH - Filippine 14
TH - Thailandia 14
SA - Arabia Saudita 12
UZ - Uzbekistan 12
JM - Giamaica 9
LT - Lituania 9
CL - Cile 8
CZ - Repubblica Ceca 8
NP - Nepal 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
DZ - Algeria 7
KZ - Kazakistan 7
MY - Malesia 7
PE - Perù 7
HU - Ungheria 6
IL - Israele 6
SD - Sudan 6
CM - Camerun 5
LB - Libano 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
RO - Romania 5
SC - Seychelles 5
TW - Taiwan 5
UY - Uruguay 5
AZ - Azerbaigian 4
CR - Costa Rica 4
ET - Etiopia 4
KG - Kirghizistan 4
NO - Norvegia 4
PA - Panama 4
BG - Bulgaria 3
BW - Botswana 3
BY - Bielorussia 3
GE - Georgia 3
HN - Honduras 3
HR - Croazia 3
KH - Cambogia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
LY - Libia 2
Totale 30.993
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.696
Ashburn 1.779
Singapore 1.504
Fairfield 1.112
Hong Kong 846
Warsaw 822
Chandler 798
Dublin 723
Seoul 589
Woodbridge 491
San Jose 485
Seattle 446
Cambridge 438
Milan 399
Beijing 384
Wilmington 370
Houston 365
Hefei 306
Ho Chi Minh City 271
Jacksonville 270
Florence 264
Buffalo 227
Los Angeles 213
Princeton 195
Lauterbourg 191
Rome 183
The Dalles 182
Ann Arbor 181
Hanoi 165
Altamura 164
Lawrence 164
Moscow 147
Boston 135
Munich 129
Boardman 127
Dallas 127
Melbourne 116
Medford 112
New York 109
Mumbai 95
Helsinki 89
Tokyo 85
Paris 79
São Paulo 79
San Diego 75
Izmir 67
Shanghai 67
Naples 60
Kent 59
Council Bluffs 56
Turin 51
Abidjan 44
Turku 44
Falls Church 40
Jakarta 39
Frankfurt am Main 38
Bologna 37
Dong Ket 37
Toronto 37
Chicago 36
Da Nang 36
Redondo Beach 35
Orem 34
Norwalk 33
Yubileyny 33
Palermo 31
Guangzhou 28
London 27
Pune 26
Montreal 25
Bari 22
Figino 22
Abuja 21
Andover 20
Genoa 20
Phoenix 20
Catania 19
Chennai 19
Clifton 19
Cotonou 19
Denver 19
Hillsboro 19
Johannesburg 19
Baghdad 18
Haiphong 18
Belo Horizonte 17
Brooklyn 17
Poplar 17
Biên Hòa 16
Shenzhen 16
Verona 16
Cagliari 15
Miano 15
San Francisco 15
Atlanta 14
Brussels 14
Bengaluru 13
Curitiba 13
Mexico City 13
Salt Lake City 13
Totale 20.265
Salva come PNG Salva come JPEG
Nome #
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis 336
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 329
[Peripheral nervous system in limited systemic sclerosis]. 329
Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: A challenge for the rheumatologist 247
Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis. 246
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 240
Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis. 238
Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit 238
Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis. 234
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 232
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 223
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 219
A rare case of Candida glabrata spondylodiscitis: case report and literature review 211
Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura 206
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 205
Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers 205
Acute heart failure in the elderly: setting related differences in clinical features and management 204
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 203
Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study. 200
Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system 199
The platypnea-orthodeoxia syndrome: an unusual case of dyspnea 196
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 196
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis 195
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. 194
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy 190
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 190
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. 189
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 188
Letter to Habets JGV et al. on “A rare case of Candida glabrata spondylodiscitis: case report and literature review” 187
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis 187
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 185
Accuracy of lung ultrasound performed with handheld ultrasound device in internal medicine: an observational study 184
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 182
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation 182
Oxidative stress in Systemic Sclerosis. 182
Dimensions of psychological dysfunction in patients with fibromyalgia: development of an Italian questionnaire. 181
HFmrEF in elderly patients hospitalised for acute heart failure: data from the ATHENA registry 181
Systemic amyloidosis: a challenge for the rheumatologist. 176
Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting 176
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 175
Amyloidoses 175
The safety of iloprost in systemic sclerosis in a real-life experience 174
Therapeutic challenges for systemic sclerosis: facts and future targets. 173
Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. 172
Dural metastasis without subdural hematoma or subdural fluid collection in a patient with signet ring cell gastric adenocarcinoma 172
Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement. 170
Are disease-related pulmonary perfusion abnormalities detectable in COVID-19 patients? Suspicious findings in a lung perfusion SPECT performed for ruling out classical pulmonary embolism 170
Therapeutic challenges for systemic sclerosis: facts and future targets. 170
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis 170
Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. 168
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. 168
The classification of hospitalized patients with hyperglycemia and its implication on outcome: results from a prospective observational study in Internal Medicine 167
Acute heart failure in the elderly: real world evidence from the ATHENA registry 167
The doctor who stared at schistocytes: an intriguing case of suspected thrombotic microangiopathic anemia 167
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database 166
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype 166
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. 163
Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis. 162
Valutazione circadiana dell’ attività fibrinolitica circolante nella Sclerosi Sistemica. 162
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. 162
Current Treatment Options in Raynaud's Phenomenon. 161
Angiotensin converting enzyme a new tool for the follow-up of endothelial injury in paediatric vasculitides. 161
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 160
EULAR EVIDENCE BASED RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGMENT OF GOUT 160
Effect of melatonin on normal and sclerodermic skin fibroblast proliferation. 160
ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC) 158
Acute heart failure in the real world: are elderly patients managed in accordance to current guidelines? Data from the ATHENA registry 158
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis   157
[Patterns of ventricular late potentials in systemic sclerosis: a noninvasive method in the study of cardiac involvement]. 156
HFmrEF in elderly patients: the pathogenetic role of ischemia. Real world data from the ATHENA registry 156
HFrEF, HFmrEF and HFpEF: which is the treatment of choice at discharge? Real world data from the ATHENA registry 156
Acute heart failure in the elderly: which are the main precipitating causes of heart failure? Real world evidence from the ATHENA registry 156
Central nervous system hemangiopericytoma with bone and lung metastases: a case report. 155
Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis: A Clinical Challenge for Cardiologists and Rheumatologists 155
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) 155
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis 155
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 155
ANGIOTENSIN CONVERTING ENZYME A NEW TOOL FOR THE FOLLOW-UPOF ENDOTHELIAL INJURY IN PEDIATRIC VASCULITIDES 154
Oral lactobacillus species in systemic sclerosis 154
High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. 153
A case of persistent hiccup after laparoscopic cholecystectomy. 153
Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression 153
Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment. 152
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases 150
Patients' unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis 149
Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. 149
Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis. 149
Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease? 149
Urokinase-type plasminogen activator is the main plasminogen activator produced by synoviocytes of osteoarthritis and rheumatoid arthitis 148
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarciodosis 148
Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach. 147
Hemorheologic profile in systemic sclerosis: role of NOS3 -786T > C and 894G >T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease. 147
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement 147
The renal resistive index: A new biomarker for the follow-up of vascular modifications in systemic sclerosis 147
POS1593-HPR GASTROINTESTINAL INVOLVEMENT IS ALREADY REPORTED IN AN ITALIAN VEDOSS COHORT: RESULTS FROM A RHEUMATOLOGICAL NURSE ASSESSMENT 147
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 146
Mycosis fungoides: from early stages to fatal central nervous system involvement 146
Tako-Tsubo like syndrome in systemic sclerosis: a sign of myocardial Raynaud Phenomenon? 145
Cardiac amyloidosis: the heart of the matter. 145
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 145
Totale 17.921
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 0 0 0 0 0 0 122
2021/20221.266 51 107 53 68 66 116 46 69 62 64 192 372
2022/20233.088 337 542 117 266 244 576 393 157 292 24 88 52
2023/20241.333 67 137 203 59 87 207 70 242 25 90 94 52
2024/20258.702 298 872 554 1.446 2.424 995 261 422 480 262 339 349
2025/202611.028 1.207 1.415 900 725 1.221 433 1.412 540 713 649 453 1.360
Totale 31.237